イブプロフェン合成 — BHCグリーンプロセス

製薬製造における受賞グリーンケミストリー

Pharmaceutical & Drug Manufacturing Global Industrial Scale $1.5 billion

概要

Ibuprofen is one of the most consumed non-steroidal anti-inflammatory drugs (NSAIDs) worldwide. The BHC Company (now BASF) developed a revolutionary three-step catalytic synthesis in the 1990s, replacing the original six-step Boots process. This green chemistry approach reduced waste by 99%, achieved near-perfect atom economy, and won the Presidential Green Chemistry Challenge Award in 1997. The process demonstrates how catalytic methods can transform pharmaceutical manufacturing.

化学プロセス

Isobutylbenzene undergoes Friedel-Crafts acylation with acetic anhydride using HF catalyst, followed by hydrogenation over Pd/C, then carbonylation with CO using Pd catalyst to yield ibuprofen in three atom-efficient steps.

C₁₀H₁₄ + (CH₃CO)₂O →[HF] C₁₂H₁₆O + CH₃COOH
C₁₂H₁₆O + H₂ →[Pd/C] C₁₂H₁₈O
C₁₂H₁₈O + CO →[Pd] C₁₃H₁₈O₂

原材料

  • Isobutylbenzene (C₁₀H₁₄) — Petrochemical synthesis (Starting material)
  • Acetic anhydride ((CH₃CO)₂O) — Ketene process (Acylating agent)
  • Carbon monoxide (CO) — Syngas (Carbonylation reagent)
  • Hydrogen gas (H₂) — Steam methane reforming (Reducing agent)

最終製品

  • Ibuprofen (C₁₃H₁₈O₂) — NSAID analgesic and anti-inflammatory (Racemic mixture, >99% purity)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

The BHC process achieves 77% atom economy versus 40% for the original Boots process, dramatically reducing waste generation. HF catalyst is recycled with >99.9% recovery. The three-step process generates minimal aqueous waste compared to the six-step alternative.

安全性の考慮事項

最新のイノベーション

Asymmetric synthesis methods producing the more active S-(+)-ibuprofen enantiomer are under development, which would halve the required dose.
Continuous flow processes are being implemented to further improve safety and efficiency.

生産規模

30000

トン/年

$1.5 billion

市場価値

もっと見る Pharmaceutical & Drug Manufacturing

アモキシシリン半合成製造

Global Industrial Scale

サリチル酸のアセチル化によるアスピリン合成

Global Industrial Scale

パラセタモール（アセトアミノフェン）合成

Global Industrial Scale

プロトンポンプ阻害剤オメプラゾール合成

Global Industrial Scale

塩酸メトホルミン合成

Global Industrial Scale

発酵によるペニシリンG製造

Global Industrial Scale

組換えヒトインスリン製造

Global Industrial Scale

Frequently Asked Questions

What industry uses イブプロフェン合成 — BHCグリーンプロセス?
イブプロフェン合成 — BHCグリーンプロセス is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in イブプロフェン合成 — BHCグリーンプロセス?
Isobutylbenzene undergoes Friedel-Crafts acylation with acetic anhydride using HF catalyst, followed by hydrogenation over Pd/C, then carbonylation with CO using Pd catalyst to yield ibuprofen in three atom-efficient steps.
What is the economic significance of イブプロフェン合成 — BHCグリーンプロセス?
イブプロフェン合成 — BHCグリーンプロセス has a market value of $1.5 billion and annual production of 30,000 tons.
What is the environmental impact of イブプロフェン合成 — BHCグリーンプロセス?
The BHC process achieves 77% atom economy versus 40% for the original Boots process, dramatically reducing waste generation. HF catalyst is recycled with >99.9% recovery. The three-step process generates minimal aqueous waste compared to the six-step alternative.
What raw materials are used in イブプロフェン合成 — BHCグリーンプロセス?
The main raw materials include: Isobutylbenzene (C₁₀H₁₄), Acetic anhydride ((CH₃CO)₂O), Carbon monoxide (CO), Hydrogen gas (H₂).